These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1803645)

  • 21. [Molecular mechanisms of antioxidant action of dalargin on the liver in experimental cholestasis].
    Korotkina RN; Fomchenkov EP; Andreev VI; Smirnova VI; Karelin AA
    Biull Eksp Biol Med; 1992 Jan; 113(1):38-40. PubMed ID: 1391860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The synthetic leu-enkephalin--dalargin--in the therapy of the irritable bowel syndrome and chronic noninfectious undefined colitis].
    Smishchuk IuO
    Lik Sprava; 1998 Jun; (4):93-6. PubMed ID: 9784715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of the intravenous infusion of dalargin on biochemical and hormonal indices in the blood of patients with duodenal peptic ulcer].
    Sokolov AS; Dmitrieva OF; Tishchenko VA
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986; 9(2):68-70. PubMed ID: 3801140
    [No Abstract]   [Full Text] [Related]  

  • 24. [Dalargin in the therapy of the exacerbations of chronic pancreatitis].
    Geller LI; Kazakevich VV; Pashko MM
    Ter Arkh; 1992; 64(8):80-2. PubMed ID: 1279830
    [No Abstract]   [Full Text] [Related]  

  • 25. [Chemiluminescence of whole saliva in antioxidant treatment of prosthetic bed tissues].
    Tunian MIu; Lalaian BK; Zakarian AE; Grigorian KL; Pogosian GA; Egiazarian AV
    Georgian Med News; 2010 Mar; (180):20-5. PubMed ID: 20413812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The use of dalargin for treating recurrent aphthous stomatitis].
    Maksimovskaia LN
    Stomatologiia (Mosk); 1995; 74(4):15. PubMed ID: 7502297
    [No Abstract]   [Full Text] [Related]  

  • 27. [The efficacy of using dalargin electrophoresis in the combined treatment of patients with ischemic heart disease].
    Ilaev TM; Ratner ZG
    Lik Sprava; 1998; (2):74-7. PubMed ID: 9670662
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effects of dalargin on some parameters of peroxidation of liver lipids in experimental animals].
    Shloznikov BM; Korotkina RN; Babkina NV; Karelin AA; Fomchenkov EP
    Biull Eksp Biol Med; 1990 Dec; 110(12):609-10. PubMed ID: 2083360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of dalargin on healing of a bullet wound of the soft tissues in rabbits].
    Legeza VP; Koshcheev AG; Konovalova LN
    Patol Fiziol Eksp Ter; 1995; (4):45-8. PubMed ID: 8700598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The effect of dalargin on the course of mechanical trauma].
    Sherman DM
    Klin Khir (1962); 1992; (9-10):28-30. PubMed ID: 1291773
    [No Abstract]   [Full Text] [Related]  

  • 31. [Transcranial electrostimulation combined with dalargin ultraphonophoresis in the treatment of patients with chronic idiopathic eczema].
    Iakushkina NIu; Silina LV; Zav'ialov AV
    Vopr Kurortol Fizioter Lech Fiz Kult; 2005; (4):25-7. PubMed ID: 16149414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The use of the polymeric sorbent Regenkur in the combined treatment of suppurative diseases of the soft tissues of the face and neck].
    Perminov AN; Kassin VIu
    Stomatologiia (Mosk); 1991; 70(3):25-7. PubMed ID: 1926199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The effect of dalargin on the opioid and immune systems in patients with a depressive syndrome].
    Zozulia AA; Shchurin MR; Dikaia VI; Bondar' VV; Krym NM; Panteleeva GP
    Zh Nevrol Psikhiatr Im S S Korsakova; 1994; 94(1):61-5. PubMed ID: 8009937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Radioimmunologic and radioreceptor studies of the pharmacokinetics of the enkephalin analog dalargin in man].
    Zaĭtsev SV; Vinogradov VA; Sergeeva MG; Dmitrieva OF; Ivanikov IO
    Biull Eksp Biol Med; 1986 Jun; 101(6):702-4. PubMed ID: 3730557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Impaired blood coagulative properties in the early postresuscitation period and their prevention].
    Dolgikh VT; Razgonov FI; Shikunova LG
    Anesteziol Reanimatol; 2004; (6):35-40. PubMed ID: 15717517
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Use of dalargin in the treatment of acute cholecystopancreatitis complicated by obstructive jaundice].
    Skomarovskiĭ ATs; Zemskov VS; Skomarovskiĭ AA
    Klin Khir; 1996; (8):13-4. PubMed ID: 9064131
    [No Abstract]   [Full Text] [Related]  

  • 37. [Results of perftorane local use in complex treatment of patients with odontogenic phlegmons of the face and neck].
    Agapov VS; Piminova IA
    Stomatologiia (Mosk); 2006; 85(5):32-5. PubMed ID: 17159841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Use of dalargin in the intensive therapy of critical conditions].
    Smirnova VI; Pulina NN; Kazennov VV; Oranskiĭ AV; Smirnov EP
    Vestn Ross Akad Med Nauk; 1994; (6):48-51. PubMed ID: 7522704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of peripheral opiate receptor agonist dalargin on exercise tolerance in patients with coronary and peripheral arteries atherosclerosis].
    Maslov LN; Fedorova NA; Dudko VA; Karpov RS
    Fiziol Cheloveka; 2002; 28(5):81-7. PubMed ID: 12397935
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of peptic ulcer hemorrhage with leucine enkephalin analog dalargin].
    Georgadze AK; Fomin VB; Bulgakov SA; Fedenko VV
    Khirurgiia (Mosk); 1990 Mar; (3):39-43. PubMed ID: 2193190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.